The role of pyroptosis in modulating the tumor immune microenvironment
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The role of pyroptosis in modulating the tumor immune microenvironment
Authors
Keywords
-
Journal
Biomarker Research
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-06-24
DOI
10.1186/s40364-022-00391-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Can inflammasomes promote the pathophysiology of glioblastoma multiforme? A view about the potential of the anti-inflammasome therapy as pharmacological target
- (2022) Giovanna Barros Rolim et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Autophagy-based unconventional secretion of HMGB1 in glioblastoma promotes chemosensitivity to temozolomide through macrophage M1-like polarization
- (2022) Zhuang Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Streptococcal pyrogenic exotoxin B cleaves GSDMA and triggers pyroptosis
- (2022) Wanyan Deng et al. NATURE
- Application of Disulfiram and its Metabolites in Treatment of Inflammatory Disorders
- (2022) Wenyi Guo et al. Frontiers in Pharmacology
- Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer
- (2022) Hongcheng Lu et al. Frontiers in Immunology
- Pyroptosis-Mediated Molecular Subtypes are Characterized by Distinct Tumor Microenvironment Infiltration Characteristics in Breast Cancer
- (2022) Lijun Xu et al. Journal of Inflammation Research
- Intravenous Delivery of Living Listeria monocytogenes Elicits Gasdmermin-Dependent Tumor Pyroptosis and Motivates Anti-Tumor Immune Response
- (2022) Yao Liu et al. ACS Nano
- Cancer statistics in China and United States, 2022: profiles, trends, and determinants
- (2022) Changfa Xia et al. CHINESE MEDICAL JOURNAL
- Interleukin-1 (IL-1) and the inflammasome in cancer
- (2022) Vincent Pretre et al. CYTOKINE
- Pan-cancer analyses of pyroptosis with functional implications for prognosis and immunotherapy in cancer
- (2022) Aibin Liu et al. Journal of Translational Medicine
- Improving CAR-T immunotherapy: Overcoming the challenges of T cell exhaustion
- (2022) Diana Gumber et al. EBioMedicine
- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Porphyromonas gingivalis Promotes Colorectal Carcinoma by Activating the Hematopoietic NLRP3 Inflammasome
- (2021) Xi Wang et al. CANCER RESEARCH
- Pyroptosis: a new paradigm of cell death for fighting against cancer
- (2021) Yixin Tan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Targeting Glycolysis in Macrophages Confers Protection Against Pancreatic Ductal Adenocarcinoma
- (2021) Hweixian Leong Penny et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Natural product triptolide induces GSDME-mediated pyroptosis in head and neck cancer through suppressing mitochondrial hexokinase-ΙΙ
- (2021) Jing Cai et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- AIM2 regulates anti-tumor immunity and is a viable therapeutic target for melanoma
- (2021) Keitaro Fukuda et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Interactions between Cancer-Associated Fibroblasts and T Cells in the Pancreatic Tumor Microenvironment and the Role of Chemokines
- (2021) Laia Gorchs et al. Cancers
- Therapeutic Potential of Targeting Stromal Crosstalk-Mediated Immune Suppression in Pancreatic Cancer
- (2021) Wenting Du et al. Frontiers in Oncology
- Overexpression of Interferon-Inducible Protein 16 Promotes Progression of Human Pancreatic Adenocarcinoma Through Interleukin-1β-Induced Tumor-Associated Macrophage Infiltration in the Tumor Microenvironment
- (2021) Jing-Xian Chen et al. Frontiers in Cell and Developmental Biology
- Immune Cell Modulation of the Extracellular Matrix Contributes to the Pathogenesis of Pancreatic Cancer
- (2021) Ramiz S. Ahmad et al. Biomolecules
- Engineering Multienzyme‐Mimicking Covalent Organic Frameworks as Pyroptosis Inducers for Boosting Antitumor Immunity
- (2021) Liang Zhang et al. ADVANCED MATERIALS
- Cancer immunogenic cell death via photo-pyroptosis with light-sensitive Indoleamine 2,3-dioxygenase inhibitor conjugate
- (2021) Yang Lu et al. BIOMATERIALS
- Zebrafish gasdermin E cleavage-engaged pyroptosis by inflammatory and apoptotic caspases
- (2021) Hao Chen et al. DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY
- Microenvironment‐Responsive Prodrug‐Induced Pyroptosis Boosts Cancer Immunotherapy
- (2021) Yao Xiao et al. Advanced Science
- DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma
- (2021) Allison A Fitzgerald et al. Journal for ImmunoTherapy of Cancer
- Antidiabetic DPP-4 Inhibitors Reprogram Tumor Microenvironment That Facilitates Murine Breast Cancer Metastasis Through Interaction With Cancer Cells via a ROS–NF-кB–NLRP3 Axis
- (2021) Rui Li et al. Frontiers in Oncology
- Gasdermin D in Different Subcellular Locations Predicts Diverse Progression, Immune Microenvironment and Prognosis in Colorectal Cancer
- (2021) Jiahui Wang et al. Journal of Inflammation Research
- Tumor Cell–Derived IL1β Promotes Desmoplasia and Immune Suppression in Pancreatic Cancer
- (2020) Shipra Das et al. CANCER RESEARCH
- Metformin activates AMPK/SIRT1/NF-κB pathway and induces mitochondrial dysfunction to drive caspase3/GSDME-mediated cancer cell pyroptosis
- (2020) Zhaodi Zheng et al. CELL CYCLE
- A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti–PD-1 immunotherapy
- (2020) Balamayoora Theivanthiran et al. JOURNAL OF CLINICAL INVESTIGATION
- Gasdermin E suppresses tumour growth by activating anti-tumour immunity
- (2020) Zhibin Zhang et al. NATURE
- FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation
- (2020) Jun Jacob Hu et al. NATURE IMMUNOLOGY
- Elevated IL18 levels in Nasopharyngeal carcinoma induced PD-1 expression on NK cells in TILS leading to poor prognosis
- (2020) Anthony Kian-Fong Liou et al. ORAL ONCOLOGY
- Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells
- (2020) Zhiwei Zhou et al. SCIENCE
- Optimization of T-cell Receptor–Modified T Cells for Cancer Therapy
- (2020) Dylan J. Drakes et al. Cancer Immunology Research
- Role of GSDMB in Pyroptosis and Cancer
- (2020) Lisha Li et al. Cancer Management and Research
- Local and systemic immunosuppression in pancreatic cancer: Targeting the stalwarts in tumor’s arsenal
- (2020) Clara S. Mundry et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy
- (2020) Ting Zhou et al. NATURE
- Cancer-derived exosomal TRIM59 regulates macrophage NLRP3 inflammasome activation to promote lung cancer progression
- (2020) Manman Liang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma
- (2020) Yunzhen Qian et al. Journal of Hematology & Oncology
- PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis
- (2020) Junwei Hou et al. NATURE CELL BIOLOGY
- Anti-cancer effect of engineered recombinant interleukin 18
- (2020) Jirakrit Saetang et al. Advances in Clinical and Experimental Medicine
- Pan-cancer analysis of NLRP3 inflammasome with potential implications in prognosis and immunotherapy in human cancer
- (2020) Mingyi Ju et al. BRIEFINGS IN BIOINFORMATICS
- NLRP3 inflammasome upregulates PD-L1 expression and contributes to immune suppression in lymphoma
- (2020) Fei Lu et al. CANCER LETTERS
- IL1β promotes immune suppression in the tumor microenvironment independent of the inflammasome and gasdermin D
- (2020) Mate Kiss et al. Cancer Immunology Research
- Serum amyloid A and inflammasome activation: A link to breast cancer progression?
- (2020) Carla Fourie et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
- (2019) Jérôme Galon et al. NATURE REVIEWS DRUG DISCOVERY
- Chemotherapeutic paclitaxel and cisplatin differentially induce pyroptosis in A549 lung cancer cells via caspase-3/GSDME activation
- (2019) Cheng-cheng Zhang et al. APOPTOSIS
- Metformin induces human esophageal carcinoma cell pyroptosis by targeting the miR-497/PELP1 axis
- (2019) Lu Wang et al. CANCER LETTERS
- NOD‐like receptor C4 Inflammasome Regulates the Growth of Colon Cancer Liver Metastasis in NAFLD
- (2019) Koichiro Ohashi et al. HEPATOLOGY
- Inflammasome inhibitors: promising therapeutic approaches against cancer
- (2019) Shengchao Xu et al. Journal of Hematology & Oncology
- Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2019) Maigeng Zhou et al. LANCET
- Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Cancer Patients
- (2019) Seon Ah Lim et al. Frontiers in Immunology
- Programmed necrotic cell death of macrophages: Focus on pyroptosis, necroptosis, and parthanatos
- (2019) Nirmal Robinson et al. Redox Biology
- Determination of the Potential Tumor-Suppressive Effects of Gsdme in a Chemically Induced and in a Genetically Modified Intestinal Cancer Mouse Model
- (2019) Lieselot Croes et al. Cancers
- Piperlongumine analogue L50377 induces pyroptosis via ROS mediated NF-κB suppression in non-small-cell lung cancer
- (2019) Qian Li et al. CHEMICO-BIOLOGICAL INTERACTIONS
- NLRP3 inflammasome in fibroblasts links tissue damage with inflammation in breast cancer progression and metastasis
- (2019) Nour Ershaid et al. Nature Communications
- Inhibition of NLRP3 inflammasome in tumor microenvironment leads to suppression of metastatic potential of cancer cells
- (2019) Hye Eun Lee et al. Scientific Reports
- Current status of terpenoids as inflammasome inhibitors
- (2019) Sonsoles Hortelano et al. BIOCHEMICAL PHARMACOLOGY
- Energy metabolism manipulates the fate and function of tumour myeloid-derived suppressor cells
- (2019) Cong Hu et al. BRITISH JOURNAL OF CANCER
- Mutant BRAF and MEK Inhibitors Regulate the Tumor Immune Microenvironment via Pyroptosis
- (2019) Dan A. Erkes et al. Cancer Discovery
- Dysregulated IL-18 Is a Key Driver of Immunosuppression and a Possible Therapeutic Target in the Multiple Myeloma Microenvironment
- (2018) Kyohei Nakamura et al. CANCER CELL
- Effect of IL-18 on the Expansion and Phenotype of Human Natural Killer Cells: Application to Cancer Immunotherapy
- (2018) Hiroaki Senju et al. International Journal of Biological Sciences
- STAT3 in Tumor-Associated Myeloid Cells: Multitasking to Disrupt Immunity
- (2018) Yu-Lin Su et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A functional splice variant associated with decreased asthma risk abolishes the ability of gasdermin B to induce epithelial cell pyroptosis
- (2018) Ronald A. Panganiban et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Engineered Tumor-Targeted T Cells Mediate Enhanced Anti-Tumor Efficacy Both Directly and through Activation of the Endogenous Immune System
- (2018) Mauro P. Avanzi et al. Cell Reports
- Interleukin-1 Beta—A Friend or Foe in Malignancies?
- (2018) Rebekka Bent et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes with anti–PD-1 for tumor abrogation
- (2018) Irena Kaplanov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Yin and Yang of Myeloid Derived Suppressor Cells
- (2018) Snehil Budhwar et al. Frontiers in Immunology
- NLRP3 Inflammasome: A Possible Link Between Obesity-Associated Low-Grade Chronic Inflammation and Colorectal Cancer Development
- (2018) Patricia Ahechu et al. Frontiers in Immunology
- NLRP3 inflammasomes in macrophages drive colorectal cancer metastasis to the liver
- (2018) Qiaoting Deng et al. CANCER LETTERS
- Metabolic pathways of L-arginine and therapeutic consequences in tumors
- (2018) Jarosław Szefel et al. Advances in Medical Sciences
- Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4
- (2017) Zdenek Skrott et al. NATURE
- Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin
- (2017) Yupeng Wang et al. NATURE
- Gasdermins: Effectors of Pyroptosis
- (2017) Stephen B. Kovacs et al. TRENDS IN CELL BIOLOGY
- LMP1-mediated glycolysis induces myeloid-derived suppressor cell expansion in nasopharyngeal carcinoma
- (2017) Ting-Ting Cai et al. PLoS Pathogens
- IL-18 receptor marks functional CD8+ T cells in non-small cell lung cancer
- (2017) Eleonora Timperi et al. OncoImmunology
- Intra-tumoral production of IL18, but not IL12, by TCR-engineered T cells is non-toxic and counteracts immune evasion of solid tumors
- (2017) A. Kunert et al. OncoImmunology
- Inflammation-Dependent IL18 Signaling Restricts Hepatocellular Carcinoma Growth by Enhancing the Accumulation and Activity of Tumor-Infiltrating Lymphocytes
- (2016) Geoffrey J. Markowitz et al. CANCER RESEARCH
- Augmentation of Immune Checkpoint Cancer Immunotherapy with IL18
- (2016) Z. Ma et al. CLINICAL CANCER RESEARCH
- Leptin promotes breast cancer cell migration and invasion via IL-18 expression and secretion
- (2016) KUANGFA LI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- NLRC4 suppresses melanoma tumor progression independently of inflammasome activation
- (2016) Ann M. Janowski et al. JOURNAL OF CLINICAL INVESTIGATION
- Obesity-associated NLRC4 inflammasome activation drives breast cancer progression
- (2016) Ryan Kolb et al. Nature Communications
- Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
- (2016) Vincenzo Bronte et al. Nature Communications
- Targeting inflammasome/IL-1 pathways for cancer immunotherapy
- (2016) Beichu Guo et al. Scientific Reports
- Blocking IL1 Pathway Following Paclitaxel Chemotherapy Slightly Inhibits Primary Tumor Growth but Promotes Spontaneous Metastasis
- (2015) T. Voloshin et al. MOLECULAR CANCER THERAPEUTICS
- Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
- (2015) Jianjin Shi et al. NATURE
- Small molecule-driven mitophagy-mediated NLRP3 inflammasome inhibition is responsible for the prevention of colitis-associated cancer
- (2014) Wenjie Guo et al. Autophagy
- Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer
- (2014) Roheena Z. Panni et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Interleukin-18 produced by bone marrow-derived stromal cells supports T-cell acute leukaemia progression
- (2014) B. Uzan et al. EMBO Molecular Medicine
- IL-18 Enhances Immunosuppressive Responses by Promoting Differentiation into Monocytic Myeloid-Derived Suppressor Cells
- (2014) Hui Xuan Lim et al. JOURNAL OF IMMUNOLOGY
- The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer
- (2010) Irving C. Allen et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A phase 2, randomized study of SB-485232, rhIL-18, in patients with previously untreated metastatic melanoma
- (2009) Ahmad A. Tarhini et al. CANCER
- Randomized Double-Blind Placebo-Controlled Trial of Thalidomide in Combination With Gemcitabine and Carboplatin in Advanced Non–Small-Cell Lung Cancer
- (2009) Siow Ming Lee et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started